Brian King

Brian King was appointed director of the Food and Drug Administration’s Center for Tobacco Products (CTP) in July 2022. In this position, King is responsible for assuring that the CTP accomplishes its public health goals and for operationalizing the center’s vision and mission as it implements the Family Smoking Prevention and Tobacco Control Act.

King has worked for nearly two decades to provide sound scientific evidence to inform tobacco control policy and to effectively communicate this information to key stakeholders, including decision-makers, the media and the general public. Prior to joining the FDA, he served as the deputy director for research translation at the Centers for Disease Control and Prevention’s (CDC) Office on Smoking and Health and more recently as the executive editor of the CDC’s Morbidity and Mortality Weekly Report Series. He has authored more than 200 scientific journal articles related to tobacco prevention and control, served as senior associate editor for multiple U.S. Surgeon General’s Reports on tobacco and was lead author of the CDC’s 2014 evidence-based guide, “Best Practices for Comprehensive Tobacco Control Programs.” 

King holds a doctorate and a Master of Public Health degree in epidemiology from the State University of New York at Buffalo.